Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-05-15 4:49 pm Purchase | 2025-03-31 | 13G | Avalo Therapeutics, Inc. AVTX | RA CAPITAL MANAGEMENT L.P. | 1,094,407 9.900% | 127,108![]() (+13.14%) | Filing History |
| 2025-05-15 4:49 pm Sale | 2025-03-31 | 13G | Verona Pharma plc VRNA | RA CAPITAL MANAGEMENT L.P. | 6,011,112 7.100% | -1,766,830![]() (-22.72%) | Filing History |
| 2025-05-15 4:48 pm Sale | 2025-03-31 | 13G | Adagio Medical Holdings, Inc. ADGM | RA CAPITAL MANAGEMENT L.P. | 1,200,000 7.200% | -413,220![]() (-25.61%) | Filing History |
| 2025-05-14 6:34 pm Purchase | 2025-05-12 | 13D | iTeos Therapeutics, Inc. ITOS | RA CAPITAL MANAGEMENT L.P. | 4,163,276 9.900% | 504,230![]() (+13.78%) | Filing History |
| 2025-05-14 6:09 pm Purchase | 2025-05-12 | 13D | Werewolf Therapeutics, Inc. HOWL | RA CAPITAL MANAGEMENT L.P. | 6,746,807 15.000% | 553,926![]() (+8.94%) | Filing History |
| 2025-05-09 4:19 pm Purchase | 2025-05-07 | 13D | LENZ Therapeutics, Inc. LENZ | RA CAPITAL MANAGEMENT L.P. | 4,260,606 15.100% | 4,260,606![]() (New Position) | Filing History |
| 2025-04-30 4:51 pm Purchase | 2025-04-28 | 13D | Jade Biosciences, Inc. JBIO | RA CAPITAL MANAGEMENT L.P. | 1,324,954 4.100% | 1,324,954![]() (New Position) | Filing History |
| 2025-04-04 4:32 pm Purchase | 2025-03-28 | 13G | Sutro Biopharma, Inc. STRO | RA CAPITAL MANAGEMENT L.P. | 4,434,637 5.300% | 4,434,637![]() (New Position) | Filing History |
| 2025-03-31 4:57 pm Purchase | 2025-03-27 | 13D | Acumen Pharmaceuticals, Inc. ABOS | RA CAPITAL MANAGEMENT L.P. | 15,016,063 24.800% | 34,445![]() (+0.23%) | Filing History |
| 2025-03-31 4:54 pm Purchase | 2025-03-27 | 13D | Tyra Biosciences, Inc. TYRA | RA CAPITAL MANAGEMENT L.P. | 10,684,890 20.100% | 7,750![]() (+0.07%) | Filing History |
| 2025-03-17 7:58 pm Purchase | 2025-03-13 | 13D | Mineralys Therapeutics, Inc. MLYS | RA CAPITAL MANAGEMENT L.P. | 6,287,597 9.900% | 1,338,290![]() (+27.04%) | Filing History |
| 2025-03-10 4:33 pm Purchase | 2025-03-06 | 13D | Janux Therapeutics, Inc. JANX | RA CAPITAL MANAGEMENT L.P. | 11,971,377 19.900% | 1,528,196![]() (+14.63%) | Filing History |
| 2025-03-03 8:17 pm Unchanged | 2025-02-27 | 13D | 89bio, Inc. ETNB | RA CAPITAL MANAGEMENT L.P. | 20,013,733 13.700% | 0 (Unchanged) | Filing History |
| 2025-02-21 4:15 pm Purchase | 2025-02-19 | 13D | Solid Biosciences Inc. SLDB | RA CAPITAL MANAGEMENT L.P. | 7,989,820 9.900% | 3,631,342![]() (+83.32%) | Filing History |
| 2025-02-18 4:25 pm Purchase | 2025-02-10 | 13D | Sionna Therapeutics, Inc. SION | RA CAPITAL MANAGEMENT L.P. | 10,445,322 23.700% | 10,445,322![]() (New Position) | Filing History |
| 2025-02-14 6:43 pm Sale | 2024-12-31 | 13G | Verona Pharma plc VRNA | RA CAPITAL MANAGEMENT L.P. | 7,777,942 8.900% | -682,148![]() (-8.06%) | Filing History |
| 2025-02-14 6:43 pm Purchase | 2024-12-31 | 13G | Unicycive Therapeutics, Inc. UNCY | RA CAPITAL MANAGEMENT L.P. | 1,152,012 9.900% | 104,775![]() (+10.00%) | Filing History |
| 2025-02-14 6:42 pm Sale | 2024-12-31 | 13G | Tenaya Therapeutics, Inc. TNYA | RA CAPITAL MANAGEMENT L.P. | 0 0.000% | -7,980,736![]() (Position Closed) | Filing History |
| 2025-02-14 6:42 pm Purchase | 2024-12-31 | 13G | NewAmsterdam Pharma Company N.V. NAMS | RA CAPITAL MANAGEMENT L.P. | 10,875,454 9.900% | 1,779,865![]() (+19.57%) | Filing History |
| 2025-02-14 6:41 pm Sale | 2024-12-31 | 13G | Recursion Pharmaceuticals, Inc. RXRX | RA CAPITAL MANAGEMENT L.P. | 7,725,096 2.000% | -7,659,519![]() (-49.79%) | Filing History |

